Report overview
Market Analysis and Insights: Global Antibody Production Services Market
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called ?antigens?). The technology behind the generation of monoclonal antibodies was discovered in 1972 by C?sar Milstein and Georges K?hler ? scientists at the Roche-funded Basel Institute for Immunology ? who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
In Vitro Diagnostics (IVD) are tests used to detect disease, infections and other medical conditions. The growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalized medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In the recent years, antibody used for IVD industry developed rapidly in China
The global Antibody Production Services market size is projected to reach US$ million by 2030, from US$ million in 2022, at a CAGR of % during 2023-2030.
Fully considering the economic change by this health crisis, IgM accounting for % of the Antibody Production Services global market in 2022, is projected to value US$ million by 2030, growing at a revised % CAGR from 2023 to 2030. While Therapeutic segment is altered to an % CAGR throughout this forecast period.
China Antibody Production Services market size is valued at US$ million in 2022, while the North America and Europe Antibody Production Services are US$ million and US$ million, severally. The proportion of the North America is % in 2022, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2030, trailing a CAGR of % through the analysis period 2023-2030. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Antibody Production Services landscape, Germany is projected to reach US$ million by 2030 trailing a CAGR of % over the forecast period 2023-2030.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antibody Production Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antibody Production Services market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antibody Production Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antibody Production Services market.
Global Antibody Production Services Scope and Market Size
Antibody Production Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Antibody Production Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030.
Segment by Type
IgM
IgG
IgA
Other
Segment by Application
Therapeutic
Research
Diagnostic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
